Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GE Medical Systems To Control U.S. C-Arm Imaging Market Via OEC Purchase

This article was originally published in The Gray Sheet

Executive Summary

GE Medical Systems will gain a controlling stake of the U.S. mobile C-arm fluoroscopy imaging market through its $480 mil. purchase of OEC Medical Systems, announced Aug. 9.

You may also be interested in...



GE Expanding Health Care Information Offerings Via $91 Mil. Mecon Buy

GE Medical Systems' planned acquisition of internet-based benchmarking and cost management services business Mecon will significantly broaden the company's health care information offerings, GE Medical says.

GE Expanding Health Care Information Offerings Via $91 Mil. Mecon Buy

GE Medical Systems' planned acquisition of internet-based benchmarking and cost management services business Mecon will significantly broaden the company's health care information offerings, GE Medical says.

PE Biosystems DNA Analyzer Demand, Strong Sales Boost Stock 26% In Q3

Continued strong demand for the ABI Prism 3700 DNA analyzer, order growth across a broad range of additional products and release of financial results ahead of some analysts' estimates contributed to a 25.9% jump in PE Biosystems' stock price during the third quarter.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012171

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel